Trial Profile
Phase IIb trial of once-daily remogliflozin etabonate in treatment-naive patients with type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jun 2015
Price :
$35
*
At a glance
- Drugs Remogliflozin etabonate (Primary) ; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Islet Sciences
- 14 Oct 2014 New trial record